Get up to 90% off - Urjas Oil X
Emletra is a prescription medicine that is available as a Tablet. Emletra also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Emletra. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Emletra also has some side effects, the most common being Headache. Some other side effects of Emletra have been listed ahead. Normally, these side effects of Emletra are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Emletra is Moderate for pregnant women and Moderate for women who are breastfeeding. Further, the section on Emletra related warnings talks about Emletra's effects on the liver, heart and kidney.
Emletra can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Emletra in conditions like Liver Disease, Hemophilia. Other contraindications of Emletra have been discussed in the sections ahead.
Drug interactions for Emletra have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Emletra is considered not safe while driving, and is not addictive.
Emletra is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Emletra is used -
Severe
Moderate
Mild
Common
Is the use of Emletra safe for pregnant women?
Emletra may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Emletra again without your doctor's advice.
Is the use of Emletra safe during breastfeeding?
Emletra can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Emletra on the Kidneys?
There are no side effects of Emletra on the kidneys.
What is the effect of Emletra on the Liver?
Very few cases of side effects of Emletra on the liver have been reported.
What is the effect of Emletra on the Heart?
Emletra has very mild side effects on the heart.
Emletra should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Emletra unless your doctor advises you to do so -
Is this Emletra habit forming or addictive?
Emletra does not cause addiction.
Interaction between Food and Emletra
Eating certain foods may increase the time it takes Emletra to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Emletra
Taking alcohol with Emletra can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvir (ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 810
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 939-941
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Kaletra (lopinavir and ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 811